Table 2 Final epitopes selected for multi-epitope vaccine construct after docking analysis with respective HLA alleles.
From: Designing a multi-epitope peptide based vaccine against SARS-CoV-2
S. no | Protein | HTL | Global energy | CTL | Global energy |
|---|---|---|---|---|---|
1 | Envelop | LLFLAFVVFLLVTLA | − 71.44 | LLFLAFVVF | − 41.45 |
2 | Envelop | LAFVVFLLVTLAILT | − 64.39 | FLLVTLAIL | − 43.31 |
3 | Membrane | TLACFVLAAVYRINW | − 53.12 | TLACFVLAA | − 54.85 |
4 | Nucleocapsid | GDAALALLLLDRLNQ | − 87.95 | GDAALALLL | − 40.49 |
5 | Nucleocapsid | AQFAPSASAFFGMSR | − 58.74 | AQFAPSASA | − 43.29 |
6 | Surface | IPFAMQMAYRFNGIG | − 46.33 | FAMQMAYRF | − 41.37 |
7 | Surface | FVFLVLLPLVSSQCV | − 74.92 | FVFLVLLPL | − 55.15 |
